Prophylaxis in MEDical Patients with ENOXaparin - MEDENOX

Description:

This randomized, double-blind, multicenter study compared two daily doses of subcutaneous enoxaparin with placebo for prevention of thromboembolism in patients hospitalized for acute medical illnesses.